Conversion of NP Thyroid 15mg to Levothyroxine
NP Thyroid 15 mg (¼ grain) should be converted to approximately 25 mcg of levothyroxine daily, though the FDA label for NP Thyroid does not provide explicit conversion ratios and this represents the lowest standard starting dose for levothyroxine.
Conversion Rationale
The conversion from desiccated thyroid extract (DTE) to levothyroxine is not straightforward because:
- DTE contains both T4 and T3 in a ratio of approximately 4:1, while levothyroxine is pure T4 1
- NP Thyroid 15 mg represents the smallest available dose (¼ grain equivalent)
- The FDA label for NP Thyroid states that usual starting doses are 30 mg, with 15 mg reserved for patients with long-standing myxedema or cardiovascular concerns 1
Practical Conversion Approach
Start with levothyroxine 25 mcg daily as the most conservative equivalent to NP Thyroid 15 mg. This represents:
- A cautious approach given the T3 content in DTE that provides more immediate metabolic activity
- The standard lowest levothyroxine starting dose for patients requiring minimal replacement
- A dose that minimizes risk of overtreatment, particularly important given that DTE therapy can cause increased heart rate and lower body weight 2
Critical Monitoring After Conversion
Check TSH and free T4 levels 4-6 weeks after conversion 3. The patient may experience:
- Temporary symptom changes as the body adjusts from having exogenous T3 (from DTE) to relying on T4-to-T3 conversion
- Need for dose adjustment based on TSH response
- The peak therapeutic effect may take 4-6 weeks to manifest 3
Dose Titration Strategy
After initial conversion:
- Adjust in 12.5-25 mcg increments every 4-6 weeks based on TSH levels 4, 3
- Target TSH within normal reference range (typically 0.5-4.5 mIU/L)
- Most patients ultimately require 60-120 mcg daily for full replacement, though this patient on only 15 mg DTE likely needs minimal replacement 1
Important Caveats
Age and cardiac considerations matter significantly:
- If patient is >50-60 years old without cardiac disease, the 25 mcg starting dose is appropriate 4
- If known coronary heart disease exists, consider starting even lower at 12.5 mcg daily 4
- Elderly patients often require 20-25% less levothyroxine per kilogram than younger patients 4
Why not use combination therapy? While some patients prefer DTE and research shows nearly half of patients in one study preferred it over levothyroxine 5, current guidelines unanimously recommend levothyroxine monotherapy as first-line treatment 6. DTE remains outside formal FDA oversight for consistency of T4 and T3 content 7, making levothyroxine the safer, more standardized choice.
The conversion should be followed by clinical assessment for symptoms of under- or over-replacement, with laboratory confirmation guiding further adjustments.